Increasing plasma potassium levels can improve outcomes in patients with CVD at high risk of ventricular arrhythmias, study ...

The role of beta-blockers after myocardial infarction in patients with LVEF is under debate, after research was unveiled at the ESC Congress.

Dr Stefania Angela Di Fusco and Prof. Furio Colivicchi share key highlights, cardiovascular research and guidelines from ESC Congress 2025.

Prof Nirmalie Wiratunga discusses the innovative iCARE Health Hub using AI to improve follow-up care for AYA cancer survivors.

Patients with psoriasis who show an early response to treatment with the biologics risankizumab or guselkumab are more likely to respond well to treatment over the long term, a new study has found.

A new app designed to reduce isolation and mental burden among young cancer patients is to undergo a national rollout across Denmark in 2024 after a successful pilot. The ‘Kræftværket‘ (The Cancer ...

The Covid-19 pandemic has temporarily reversed years of progress in life expectancy for people in Bulgaria, for whom life expectancy was already the lowest in the EU in 2019. Despite health system ...

Moving medical supplies via drone was once a farfetched idea, but there are now multiple projects working to make it a reality. Kathy Oxtoby considers five case studies from the UK and the Netherlands ...

Speaking at Hospital Healthcare Europe’s Spring 2025 Clinical Excellence in Respiratory Care event, Dr Sophie West focused on the use of wearables and artificial intelligence in the future of sleep ...

Senior doctors should get flexible or part-time working options and from the age of 60 should opt into on‐call only if they wish to, according to joint guidance from the Royal College of Physicians ...

Understanding the factors contributing to child deaths is essential not only for supporting bereaved families but also driving systemic improvements in prevention and care. While many countries have ...

The cystic fibrosis (CF) medication ivacaftor (brand name Kalydeco) is safe and effective in infants aged four weeks and over, paving the way for earlier initiation of therapy for newborns diagnosed ...